37 related articles for article (PubMed ID: 21155886)
1. Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC.
Matsuda M; Asakawa M; Amemiya H; Fujii H
J Gastroenterol Hepatol; 2011 Apr; 26(4):731-8. PubMed ID: 21155886
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Lens culinaris agglutinin reactive alpha-fetoprotein and biological features of hepatocellular carcinoma.
Kusaba T
Kurume Med J; 1998; 45(1):113-20. PubMed ID: 9658760
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study.
Jitpraphawan O; Ruamtawee W; Treewatchareekorn M; Sethasine S
World J Gastroenterol; 2024 May; 30(17):2343-2353. PubMed ID: 38813057
[TBL] [Abstract][Full Text] [Related]
4. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions.
Ugonabo O; Udoh US; Rajan PK; Reeves H; Arcand C; Nakafuku Y; Joshi T; Finley R; Pierre SV; Sanabria JR
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759769
[TBL] [Abstract][Full Text] [Related]
5. Development and application of hepatocellular carcinoma risk prediction model based on clinical characteristics and liver related indexes.
Liu ZJ; Xu Y; Wang WX; Guo B; Zhang GY; Luo GC; Wang Q
World J Gastrointest Oncol; 2023 Aug; 15(8):1486-1496. PubMed ID: 37663947
[TBL] [Abstract][Full Text] [Related]
6. Capitalizing glycomic changes for improved biomarker-based cancer diagnostics.
Silva MLS
Explor Target Antitumor Ther; 2023; 4(3):366-395. PubMed ID: 37455827
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Perne MG; Sitar-Tăut AV; Alexescu TG; Ciumărnean L; Milaciu MV; Coste SC; Vlad CV; Cozma A; Sitar-Tăut DA; Orăşan OH; Crăciun A
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36899960
[TBL] [Abstract][Full Text] [Related]
8. The Predictive Value of CA-125 and Hb for Ocular Metastasis in Hepatocellular Carcinoma Patients.
Xiong X; Rong R; Tang LY; Sun T; Pan YC; Shu HY; Zhang LJ; Ge QM; Liang RB; Shao Y
Cancer Manag Res; 2022; 14():3405-3415. PubMed ID: 36504761
[TBL] [Abstract][Full Text] [Related]
9. Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment.
Xiong Y; Cao P; Lei X; Tang W; Ding C; Qi S; Chen G
World J Surg Oncol; 2022 Sep; 20(1):328. PubMed ID: 36180867
[TBL] [Abstract][Full Text] [Related]
10. Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
Rich NE; Singal AG
Hepatology; 2022 Mar; 75(3):740-753. PubMed ID: 34923659
[TBL] [Abstract][Full Text] [Related]
11. Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases.
Tarao K; Nozaki A; Komatsu H; Komatsu T; Taguri M; Tanaka K; Chuma M; Numata K; Maeda S
World J Hepatol; 2020 Nov; 12(11):1046-1054. PubMed ID: 33312428
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for hepatocellular cancer.
Singh G; Yoshida EM; Rathi S; Marquez V; Kim P; Erb SR; Salh BS
World J Hepatol; 2020 Sep; 12(9):558-573. PubMed ID: 33033565
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.
Piñero F; Dirchwolf M; Pessôa MG
Cells; 2020 Jun; 9(6):. PubMed ID: 32492896
[TBL] [Abstract][Full Text] [Related]
14. Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray.
Wu M; Liu H; Liu Z; Liu C; Zhang A; Li N
J Int Med Res; 2018 Oct; 46(10):4297-4305. PubMed ID: 30111217
[TBL] [Abstract][Full Text] [Related]
15. Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.
Setsu T; Tsuchiya A; Watanabe T; Nagoya T; Ikarashi S; Hayashi K; Yokoyama J; Yamagiwa S; Terai S
Case Rep Gastroenterol; 2017; 11(1):142-147. PubMed ID: 28611567
[TBL] [Abstract][Full Text] [Related]
16. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma.
Matsuda M
World J Hepatol; 2015 Dec; 7(30):2933-9. PubMed ID: 26730272
[TBL] [Abstract][Full Text] [Related]
18. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.
Schütte K; Schulz C; Link A; Malfertheiner P
World J Hepatol; 2015 Feb; 7(2):139-49. PubMed ID: 25729470
[TBL] [Abstract][Full Text] [Related]
19. Preoperative gadoxetic Acid-enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection.
Matsuda M; Ichikawa T; Amemiya H; Maki A; Watanabe M; Kawaida H; Kono H; Sano K; Motosugi U; Fujii H
HPB Surg; 2014; 2014():641685. PubMed ID: 24701029
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
